Covered recipient · General Payments record
GRACE WALKUP
General Payments · PY2023–2024
$469.23
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $424.71 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $164.24 | 8 |
| Phathom Pharmaceuticals, Inc. | $135.00 | 1 |
| Acerta Pharma LLC | $27.54 | 2 |
| Otsuka America Pharmaceutical, Inc. | $20.94 | 1 |
| Astellas Pharma US Inc | $20.67 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.53 | 1 |
| DEXCOM, INC. | $19.08 | 1 |
| Novo Nordisk AS | $17.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.62 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300127 | CMS |
| ABBVIE INC. | $12.69 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300129 | CMS |
| ABBVIE INC. | $12.61 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300131 | CMS |
| ABBVIE INC. | $14.27 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300133 | CMS |
| ABBVIE INC. | $26.75 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300135 | CMS |
| ABBVIE INC. | $32.98 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300137 | CMS |
| ABBVIE INC. | $18.22 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300139 | CMS |
| ABBVIE INC. | $33.10 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300141 | CMS |
| Astellas Pharma US Inc | $20.67 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140286837 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.10 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110510102 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.44 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110510316 | CMS |
| Dexcom, Inc. | $19.08 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153302127 | CMS |
| Novartis Pharmaceuticals Corporation | $19.53 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087430918 | CMS |
| Novo Nordisk Inc | $17.71 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108582337 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.94 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119001675 | CMS |
| Phathom Pharmaceuticals, Inc. | $135.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151137347 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.